1.Li CP#, Cai MY#, Jiang LJ#, Mai SJ, Chen JW, Wang FW, Liao YJ, Chen WH, Jin XH, Pei XQ, Guan XY, Zeng MS, Xie D*.CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma. Carcinogenesis. 2016 Jun;37(6):557-566.
2. Jiang L#, Dong P#, Zhang Z#,Li C#, Li Y, Liao Y, Li X, Wu Z, Guo S, Mai S, Xie D, Liu Z, Zhou F*. Akt phosphorylates Prohibitin 1 to mediate its mitochondrial localization and promote proliferation of bladder cancer cells. Cell Death Dis. 2015 Feb 26;6(2):e1660.
3. Zhang M, Li Q, Yang T, Meng F, Lai X, Liang L,Li C, Sun H, Sun J, Zheng H*.Positive feedback between retinoic acid and 2-phospho-L-ascorbic acid trisodium salt during somatic cell reprogramming. Cell Regen. 2020 Oct 1;9(1):17.
4. Meng F, Li Y, Sun H,Li C, Li Q, Law PY, Loh HH, Liang L, Zheng H. Naloxone Facilitates Contextual Learning and Memory in a Receptor-Independent and Tet1-Dependent Manner. Cell Mol Neurobiol. 2020 Sep 28. doi: 10.1007/s10571-020-00970-8.
5. Sun H, Yang X, Liang L, Zhang M, Li Y, Chen J, Wang F, Yang T, Meng F, Lai X,Li C, He J, He M, Xu Q, Li Q, Lin L, Pei D, Zheng H. Metabolic switch and epithelial-mesenchymal transition cooperate to regulate pluripotency. EMBO J. 2020 Apr 15;39(8):e102961. doi: 10.15252/embj.2019102961.
專利申請
1.“一類可提高維生素C抗腫瘤效果的藥物組合物”、鄭輝、李長朋、王付卉、申請號:PIDC3205852,已受理;